Exploring how short RNAs regulate gene activity
Involvement of Noncanonical Short RNAs in Gene Repression through the RNA-Induced-Silencing Complex
This study is looking at tiny RNA molecules and how they help control gene activity, which could lead to better treatments for patients by improving our understanding of how genes work.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11095245 on NIH RePORTER |
What this research studies
This research investigates a new family of short RNAs and their role in gene repression through a complex known as the RNA-Induced Silencing Complex (RISC). The team aims to enhance their ability to prepare specific cDNA libraries from these short RNAs using advanced equipment, which will allow for more precise studies of gene regulation. By focusing on the size selection of cDNAs, the research seeks to uncover how these short RNAs function in cellular processes. Patients may benefit from a deeper understanding of gene expression regulation, which could lead to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to gene expression dysregulation, such as certain cancers or genetic disorders.
Not a fit: Patients with conditions unrelated to gene regulation or those who do not have access to the research facilities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that target gene regulation in various diseases.
How similar studies have performed: Other research has shown promising results in understanding gene regulation through RNA mechanisms, indicating that this approach has potential for success.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Dutta, Anindya — University of Alabama at Birmingham
- Study coordinator: Dutta, Anindya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.